November Candlesticks 🕯️

The month of November is in the books! 📚 Here’s a curated list of the monthly rippers and dippers for your viewing pleasure.

The S&P 500 poked its head into new highs, but closed the month 0.83% lower. $SPX has finished 8/11 months of 2021 positive so far. 🍀

NVIDIA proved itself as one of the strongest metaverse plays on the market. 💪 $NVDA launched 27.81% to record prices.

Lucid raced ahead to a new monthly high. $LCID leaped 32.53% on the highest volume it has ever traded.

Peloton deflated 51.9% and had its worst monthly performance ever. $PTON is down 71.2% YTD, oof… 

Merck & Co. The market said “not so fast” to $MRK as the biotech pulled back 15% from highs and erased all of October’s gains. 

Learn More About...

More in   Stocks

View All

Investors Ditch China For Nvidia

While everyone is looking at the S&P 500 closing above 5,000 as this week’s stat of the week, MarketWatch is flagging another wild data point. 🚨

As you can see from the headline snippet above, Nvidia is now worth as much as the entire Chinese stock market. While several stocks already have achieved this feat, they’re bigger conglomerates with many businesses under one roof. But Nvidia is a chip designer and manufacturer with a more straightforward business model, making this that much crazier of an occurrence. 

Read It

Investors Chew On New Opportunities

With the stock market looking to close out an epic fourth-quarter run and overall 2023, investors and traders continue to look for opportunities in beaten-down areas of the market. 🕵️‍♂️

One of the stocks popping up on traders’ radars today is online pet retailer Chewy. The last time we checked in on the stock was in September when the trend of investors ditching unprofitable companies pushed shares to new all-time lows.

Read It

Stocktwits 2023 Year In Review

What a year it’s been for markets in 2023, with crypto soaring, tech stocks battling back, the economy staying upright, regional banks collapsing, and the Fed setting the stage to cut rates. 

The Stocktwits community was on top of it all, so what better way to recap the year than with some of our platform’s unique data? Let’s dive into it. 👇

Read It

Biotech Investors Target PHAT Gains

As we’ve been highlighting for a long time, investors and traders continue to seek opportunities in the micro and small-cap healthcare space in hopes of a buyout.

With the most prominent players sitting on tons of cash and needing their next growth driver, it seems like there’s a new company being acquired every day. 🤑

Read It